US Patent Issued to Genentech on Aug. 4 for "Methods for modulating host cell surface interactions with SARS-CoV-2" (California Inventor)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,322, issued on Aug. 4, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Methods for modulating host cell surface interactions with SARS-CoV-2" was invented by Nadia Martinez-Martin (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating or preventing SARS-CoV-2 infection comprising modulating interactions between the SARS-CoV-2 spike protein and plasma membrane-expressed host cell proteins, as well as methods of identifying modulators of such interactions."

The patent was filed on May 22, 2023, under Application No. 18/321,396.

*For further information, including images, char...